Cargando…

Multiple endocrine neoplasia 2: an overview

This review article discusses the diagnosis and treatment of patients with multiple endocrine neoplasia type 2 (MEN2). The most common tumors associated with MEN2 are those of the parathyroid, thyroid, and adrenal glands. Additional manifestations include characteristic clinical phenotypes or featur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saravana-Bawan, B, Pasternak, JD
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	New Perspectives in the Diagnosis and Treatment of Endocrine Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882936/ https://www.ncbi.nlm.nih.gov/pubmed/35237400 http://dx.doi.org/10.1177/20406223221079246

Ejemplares similares

Multiple endocrine neoplasia 1: a broad overview
por: Thompson, Rachel, et al.
Publicado: (2021)

Is eNAMPT/visfatin a potential serum marker of papillary thyroid cancer?
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2022)

Clinicopathological parameters for predicting non-invasive follicular thyroid neoplasm with papillary features (NIFTP)
por: Jang, Eunju, et al.
Publicado: (2021)

Advancements in the treatment of differentiated thyroid cancer
por: Stewart, Latoya A., et al.
Publicado: (2021)

Medullary thyroid carcinoma: recent advances in identification, treatment, and prognosis
por: Bartz-Kurycki, Marisa A., et al.
Publicado: (2021)

Evolution of anaplastic thyroid cancer management: perspectives in the era of precision oncology
por: Agosto Salgado, Sarimar
Publicado: (2021)

Advances in the diagnosis and the management of primary hyperparathyroidism
por: Islam, Ana Kashfia
Publicado: (2021)

Clinical and molecular characterization of thyroid cancer when seen as a second malignant neoplasm
por: Romanelli, Kristen, et al.
Publicado: (2021)

Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment
por: Shariq, Omair A., et al.
Publicado: (2021)

A New Medical Therapy for Multiple Endocrine Neoplasia Type 1?
por: Boharoon, Hessa, et al.
Publicado: (2022)

RF27 | LBSUN361 Understanding The Genetics Of Multiple Endocrine Neoplasia Type 1: The Road Ahead
por: Worthy, Charlita
Publicado: (2022)

Spindle cell carcinoma of the breast managed with neoadjuvant AIM: A case report
por: Choi, April, et al.
Publicado: (2020)

A giant thoraco abdominal wall lipoma in a child
por: Aihole, Jayalaxmi Shripati
Publicado: (2020)

Angiosarcoma: A population-based cancer registry descriptive study of 45 consecutive cases diagnosed between 1979 and 2016
por: Colas, Morgane, et al.
Publicado: (2020)

Epithelioid hemangioendothelioma of bone: A survival analysis of 50 cases from the SEER database (1992–2016)
por: Gusho, Charles A, et al.
Publicado: (2021)

Intraosseous ancient Schwannoma: A rare case in the mandible and a literature review
por: Kardouni Khoozestani, Neda, et al.
Publicado: (2021)

Nature and significance of stromal differentiation in carcinosarcoma (MMMT): unravelling the biology and shifting current paradigms
por: Hacking, Sean, et al.
Publicado: (2021)

Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1
por: Jhawar, Sakshi, et al.
Publicado: (2019)

Strategic Impact of a New Academic Endocrine Surgery Program
por: Wiseman, James E., et al.
Publicado: (2011)

Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer
por: Xia, Song, et al.
Publicado: (2022)

Early Application of Palbociclib Plus Endocrine Therapy in HR+/HER2− Metastatic Breast Cancer: A Better Choice Based on Data From the Chinese Population
por: Zhang, Yusi, et al.
Publicado: (2022)

Diagnosis: Multiple endocrine neoplasia type 1 (MEN 1), also known as Wermer’s syndrome
por: Das, Chandan Jyoti, et al.
Publicado: (2007)

Hypoxia and the Tumor Microenvironment
por: Li, Yue, et al.
Publicado: (2021)

Silica-Coated Fe(3)O(4) Nanoparticles as a Bifunctional Agent for Magnetic Resonance Imaging and ZnII Fluorescent Sensing
por: Qiu, Lin, et al.
Publicado: (2021)

Tumor Targeting by Conditioned Medium Derived From Human Amniotic Membrane: New Insight in Breast Cancer Therapy
por: Jafari, Ameneh, et al.
Publicado: (2021)

Identification of a Signature Comprising 5 Soluble Carrier Family Genes to Predict the Recurrence of Papillary Thyroid Carcinoma
por: Han, Rui, et al.
Publicado: (2021)

Next Generation Sequencing Reveals Pathogenic and Actionable Genetic Alterations of Soft Tissue Sarcoma in Chinese Patients: A Single Center Experience
por: Jin, Gu, et al.
Publicado: (2021)

Multiple endocrine neoplasias: an overview of recent progress
por: Rocha-e-Silva, Mauricio, et al.
Publicado: (2012)

TACE Combined with Lenvatinib and Camrelizumab for Unresectable Multiple Nodular and Large Hepatocellular Carcinoma (>5 cm)
por: Xiang, Zhanwang, et al.
Publicado: (2023)

Challenges and Opportunities for Diabetes Care in the Philippines in the Time of the COVID-19 Pandemic
por: Elvira Arcellana, Anna, et al.
Publicado: (2020)

Novel Assay for Detection of Progesterone Receptor-Interacting Endocrine Disruptors
por: Stavreva, Diana A, et al.
Publicado: (2021)

MON-LB008 PD-L1 Expression in Normal Endocrine Tissues
por: Pollack, Rena, et al.
Publicado: (2019)

The Association of the Polychlorinated Biphenyl Class of Endocrine Disruptors With Polycystic Ovary Syndrome and Thyroid Dysfunction
por: Brennan, Edwina, et al.
Publicado: (2021)

Limited disease progression in endocrine surgery patients with treatment delays due to COVID-19
por: Collins, Reagan A., et al.
Publicado: (2023)

A Phase 2a dose‐escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS‐986231 in hospitalized patients with heart failure with reduced ejection fraction
por: Tita, Cristina, et al.
Publicado: (2017)

MON-035 Aldosterone Secretion in a Human Adrenal Cell Line Is Enhanced by the Endocrine-Disrupting Chemical Di-(2-Ethylhexyl) Phthalate (DEHP)
por: Schupbach, Chad, et al.
Publicado: (2019)

A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study
por: Gordon, J, et al.
Publicado: (2010)

OR23-1 Transgenerational Effects of Endocrine Disrupting Chemicals on Pubertal Timing through Epigenetic Reprogramming of the Hypothalamus
por: Lopez Rodriguez, David, et al.
Publicado: (2019)

In-Vitro Exposure to Endocrine Disruptors Alters Inflammatory Markers in Whole Hypothalami and Immortalized GnRH Neurons
por: Riaño, Juan Manuel, et al.
Publicado: (2021)

The Importance of Evaluating Serum Levels of Tumor Markers M2-PK and Inhibin A in Patients Undergoing Colonoscopy
por: Khosravi, Mahmood, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4l0mb8v7beac3qkjaff4q5rlpe